
    
      A randomized controlled clinical trial involving patients 0-3 yrs old with type 1 diabetes.
      After successful screening the subjects will be randomized into one of two groups: a CSII
      group alone and a CSII group + Real Time Sensor Augmentation group (RTSA) group. The CSII
      group will serve as the control for the CSII+RTSA group. The trial will last for one year.
    
  